default author photo

Song-Yang Wu

Fudan University - Shanghai Cancer Center (FUSCC)

China

  • Fudan University - Shanghai Cancer Center (FUSCC)

SCHOLARLY PAPERS

2

DOWNLOADS

160

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Neoadjuvant Anthracycline Followed by Toripalimab Combined with Nab-Paclitaxel in Patients with Early Triple-Negative Breast Cancer (NeoTENNIS): A Single-Arm, Phase II Study

Downloads 121 (596,393)
Citation 1

Neoadjuvant Anthracycline Followed by Toripalimab Combined with Nab-Paclitaxel in Patients with Early Triple-Negative Breast Cancer (NeoTENNIS): A Single-Arm, Phase II Study

Number of pages: 31 Posted: 04 Jan 2024
Min He, Shuang Hao, Lin-Xiaoxi Ma, Bing-Qiu Xiu, Ben-Long Yang, Ze-Hao Wang, Jing-Yan Xue, Ya-Yun Chi, Min Xiong, Jia-Jian Chen, Xiao-Yan Huang, Xi-Yu Liu, Song-Yang Wu, Qin Xiao, Yan Huang, Ruo-Hong Shui, A-Yong Cao, Jun-Jie Li, Gen-Hong Di, Wen-Tao Yang, Xin Hu, Guang-Yu Liu, Ke-Da Yu, Yi-Zhou Jiang, Zhong-Hua Wang, Zhi-Ming Shao and Jiong Wu
Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University - Shanghai Cancer Center (FUSCC), Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University and Fudan University - Department of Breast Surgery
Downloads 64 (938,792)
Citation 1

Abstract:

Loading...

triple-negative breast cancer, neoadjuvant therapy, immune checkpoint inhibitor, induction treatment, de-escalation

Neoadjuvant Anthracycline Followed by Toripalimab Combined with Nab-Paclitaxel in Patients with Early Triple-Negative Breast Cancer (NeoTENNIS): A Single-Arm, Phase II Study

Number of pages: 49 Posted: 19 Apr 2024
Min He, Shuang Hao, Lin-Xiaoxi Ma, Bing-Qiu Xiu, Ben-Long Yang, Ze-Hao Wang, Jing-Yan Xue, Ya-Yun Chi, Min Xiong, JiaJian Chen, XiaoYan Huang, Xi-Yu Liu, Song-Yang Wu, Qin Xiao, Yan Huang, Ruo-Hong Shui, AYong Cao, Junjie Li, GenHong Di, Wen-Tao Yang, Xin Hu, Guang-Yu Liu, Ke-Da Yu, Yi-Zhou Jiang, ZhongHua Wang, Zhi-Ming Shao and Jiong Wu
Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University - Shanghai Cancer Center (FUSCC), Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University - Department of Oncology, Fudan University, Fudan University - Department of Breast Surgery, Fudan University - Department of Breast Surgery, Fudan University - Department of Breast Surgery, Fudan University, Fudan University - Department of Breast Surgery and Fudan University - Department of Breast Surgery
Downloads 57 (1,017,159)

Abstract:

Loading...

Triple-negative breast cancer, Neoadjuvant therapy, Immune checkpoint inhibitor, Induction treatment, De-escalation

2.

The RNA N 6-Methyladenosine Modification Landscape of Triple-Negative Breast Cancer Reveals its Role in DNA Damage Repair

Number of pages: 52 Posted: 21 Mar 2022
Ding Ma, Si-Yuan Li, Qin Li, Zhen Wang, Song-Yang Wu, Fan Yang, Yi-Zhou Jiang, Shenglin Huang and Zhi-Ming Shao
Fudan University - Shanghai Cancer Center (FUSCC), Fudan University - Shanghai Cancer Center (FUSCC), Fudan University - Shanghai Cancer Center (FUSCC), Fudan University - The International Co-laboratory of Medical Epigenetics and Metabolism (MOE), Fudan University - Shanghai Cancer Center (FUSCC), Fudan University - Shanghai Cancer Center (FUSCC), Fudan University - Department of Breast Surgery, Fudan University - The International Co-laboratory of Medical Epigenetics and Metabolism (MOE) and Fudan University - Department of Breast Surgery
Downloads 39 (1,196,171)

Abstract:

Loading...

m6A, triple-negative breast cancer, MeRIP-seq, Multi-omics, DNA repair, PARP inhibitor